In this study, researchers are looking at how safe and effective it is to use vosaroxin and cytarabine together for the treatment of acute myeloid leukemia (AML). They will compare this therapy with cytarabine given alone.
Vosaroxin is an investigational medication and has been given to more than 550 people with different kinds of cancer, including AML. Cytarabine is a marketed medication commonly used to treat AML. The study will determine if survival is different between the two treatment groups.